FindTrial
Sign In

Comparison of ultrasound images of patients with head and neck tumor before and after radiotherapy

Ultrasonic evaluation of toxicity of radiotherapy in patients with head and neck tumor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057364
Enrollment
Unknown
Registered
2022-03-09
Start date
2022-03-15
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Gold Standard:Pathologically diagnosed with head and neck cancer
Index test:Ultrasound, CT, MRI

Sponsors

Sichuan Cancer Hospital Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathologically diagnosed as primary malignant tumors of the head and neck (nasopharyngeal carcinoma, laryngeal carcinoma, oral squamous cell carcinoma, etc.); 2. The above-mentioned diagnosed patients have been prescribed the treatment plan by the clinician including radiotherapy; 3. Sign the informed consent form, and they have to underwent ultrasound imaging before radiotherapy, in the short and long term after radiotherapy.

Exclusion criteria

Exclusion criteria: 1. Patients who have not completed the radiotherapy cycle; 2. Patients who do not agree to follow-up examinations or who cant answer or die during the follow-up period; 3. Patients whose tumors are not primary; 4. patients with skin ulceration cannot be applied with coupling agent patient or take us examination.

Design outcomes

Primary

MeasureTime frame
skin thickness;the size of salivary glands;sternocleidomastoid width;—

Countries

China

Contacts

Public ContactMan Lu

Sichuan Cancer Hospital Institute

graceof@163.com+86 18908190051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026